N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition

  • Acta Crystallogr C. 2002 Oct;58(Pt 10):o621-3. doi: 10.1107/s0108270102016463.
Catherine Michaux  1 ,  Jean-Michel Dogné ,  Bernadette Norberg ,  François Durant ,  Bernard Masereel
Affiliations
  • 1. Laboratoire de Chimie Moléculaire Structurale, Facultés Universitaires N-D de la Paix, 61 Rue de Bruxelles, B-5000 Namur, Belgium. [email protected]
PMID: 12359948 DOI: 10.1107/s0108270102016463
Abstract

The title compound (BM531), C(17)H(26)N(4)O(5)S, has been designed for use as both a thromboxane synthase inhibitor (TXSI) and a thromboxane receptor antagonist (TXRA). We report here the X-ray crystal structure determination of the compound.

Products